Skip to main content
ADUS
NASDAQ Industrial Applications And Services

Addus HomeCare Q2 Revenue Rises 8% to $377M, Net Income Up 25%

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$113.66
Mkt Cap
$2.121B
52W Low
$87.95
52W High
$124.435
52W Position info
29% above low
Off High info
8.7% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

ADUS sits 29% above its 52-week low of $87.95.

Summary

Addus HomeCare posted Q2 2026 revenue of $377.4 million, an 8% year-over-year increase, as net income rose 25% to $27.6 million. Robust cash generation enabled a $60 million debt paydown.


Key Events · Earnings and Guidance · ADUS

  • Revenue Up 8% to $377.4M

    Driven by personal care segment gains from acquisitions and organic billable hour growth, Q2 2026 net service revenues rose 8% year-over-year to $377.4 million.

  • Net Income Jumps 25% to $27.6M

    Net income reached $27.6 million, or $1.49 per diluted share, compared to $22.1 million, or $1.20 per share, in Q2 2025.

  • Operating Cash Flow More Than Doubles

    Cash from operations surged to $92.4 million for the first half of 2026, up from $41.5 million a year ago, fueled by improved receivables collection.

  • Debt Reduced by $60 Million

    The company repaid $60 million on its revolving credit facility, bringing outstanding borrowings to $64.3 million with $577.8 million available.


Analysis · ADUS · Industrial Applications And Services

A strong second quarter underscores Addus HomeCare's profitable growth trajectory. Revenue climbed 8% to $377.4 million, while net income surged 25% to $27.6 million, powered by the personal care segment's acquisitions and organic billable hour expansion. Operating cash flow more than doubled to $92.4 million in the first half, providing the firepower to slash $60 million in revolving debt. The balance sheet remains robust, with $577.8 million available on the credit facility. The lone blemish is the home health segment, where revenue slipped on lower patient volumes. Overall, the quarter highlights the company's ability to expand earnings while strengthening its financial position.

At the time of this filing, ADUS was trading at $113.66 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.1B. The 52-week trading range was $87.95 to $124.44. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ADUS - Latest Insights

ADUS
Aug 03, 2026, 4:25 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $112.50
Real-time Price: $109.00 info
Change: -$3.50 (-3%) info
Market Cap: $2.121B info
ADUS
May 05, 2026, 4:30 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $98.44
Real-time Price: $109.00 info
Change: +$10.56 (+11%) info
Market Cap: $2.121B info
ADUS
May 04, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $96.58
Real-time Price: $109.00 info
Change: +$12.42 (+13%) info
Market Cap: $2.121B info
ADUS
Feb 24, 2026, 4:31 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $105.20
Real-time Price: $109.00 info
Change: +$3.80 (+4%) info
Market Cap: $2.121B info
ADUS
Feb 23, 2026, 4:16 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $117.63
Real-time Price: $109.00 info
Change: -$8.63 (-7%) info
Market Cap: $2.121B info